Beam Therapeutics Inc. Prepaid Expense and Other Assets, Current
Beam Therapeutics Inc. (BEAM) had Prepaid Expense and Other Assets, Current of $25.67 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Notes
us-gaap:PrepaidExpenseAndOtherAssetsCurrent · last filed 2026-08-04
- 2026-06-30: Prepaid Expense and Other Assets, Current $25.67M.
- 2026-03-31: Prepaid Expense and Other Assets, Current $55.30M.
- 2025-12-31: Prepaid Expense and Other Assets, Current $23.48M.
- 2025-09-30: Prepaid Expense and Other Assets, Current $23.58M.
| Period end | Prepaid Expense and Other Assets, Current |
|---|---|
| 2026-06-30 | $25.67M 10-Q · filed 2026-08-04 |
| 2026-03-31 | $55.30M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $23.48M 10-Q · filed 2026-08-04 |
| 2025-09-30 | $23.58M 10-Q · filed 2025-11-04 |
| 2025-06-30 | $25.13M 10-Q · filed 2025-08-05 |
| 2025-03-31 | $27.66M 10-Q · filed 2025-05-06 |
| 2024-12-31 | $27.41M 10-K · filed 2026-02-24 |
| 2024-09-30 | $19.78M 10-Q · filed 2024-11-05 |
| 2024-06-30 | $21.27M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $27.16M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $21.17M 10-K · filed 2025-02-25 |
| 2023-09-30 | $24.08M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $21.79M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $23.56M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $14.76M 10-K · filed 2024-02-27 |
| 2022-09-30 | $14.36M 10-Q · filed 2022-11-07 |
| 2022-06-30 | $13.78M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $16.88M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $7.36M 10-K · filed 2023-02-28 |
| 2021-09-30 | $8.02M 10-Q · filed 2021-11-08 |
| 2021-06-30 | $12.71M 10-Q · filed 2021-08-10 |
| 2021-03-31 | $11.10M 10-Q · filed 2021-05-11 |
| 2020-12-31 | $8.65M 10-K · filed 2022-02-28 |
| 2020-09-30 | $6.49M 10-Q · filed 2020-11-10 |
| 2020-06-30 | $6.88M 10-Q · filed 2020-08-12 |
| 2020-03-31 | $6.19M 10-Q · filed 2020-05-12 |
| 2019-12-31 | $2.70M 10-K · filed 2021-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |